Mission Therapeutics
PrivateLast Round
Series D
Extension
Oct 15, 2025
Est. Valuation
$115.4M
Total Funding Raised
$183.55M
Company Overview
Mission Therapeutics is a pharmaceutical research and drug discovery company that develops first-in-class therapeutics targeting deubiquitylating enzymes to treat serious diseases including neurodegenerative conditions, fibrosis, and rare mitochondrial disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Mission Therapeutics Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Mission Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D Extension | Oct 15, 2025 | ||||
| Grant | Jul 2, 2024 | ||||
| Series D | Mar 14, 2024 | ||||
| Grant | Oct 12, 2021 | ||||
| VC Round | Jul 6, 2020 | ||||
Series C | Feb 2, 2016 |
Mission Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Roche Venture Fund | Series A, Series C, Series B, VC Round, Series D Extension, Series D |
| IP Group | VC Round, Series D, Series D Extension |
| Parkinson's UK | Grant |
| Woodford Investment Management | Series C |
| Innovate UK | Grant |
| Roche Venture Fund | Series B, VC Round, Series D, Series D Extension, Series A, Series C |
| The Michael J. Fox Foundation for Parkinson's Research | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 27, 2025
Preclinical laboratory operations in Cambridge, UK are closing.
Mission Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Mission Therapeutics's valuation, stock price, and market status.